| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 68 | 2019 | 494 | 9.310 |
Why?
|
| Photoaffinity Labels | 32 | 2020 | 85 | 5.050 |
Why?
|
| Torpedo | 62 | 2019 | 170 | 4.300 |
Why?
|
| Receptors, GABA-A | 24 | 2020 | 625 | 3.850 |
Why?
|
| Nicotinic Antagonists | 20 | 2016 | 94 | 3.100 |
Why?
|
| Etomidate | 17 | 2020 | 185 | 2.980 |
Why?
|
| Nicotinic Agonists | 13 | 2016 | 266 | 2.240 |
Why?
|
| Fish Proteins | 4 | 2019 | 48 | 2.000 |
Why?
|
| Barbiturates | 5 | 2017 | 113 | 1.960 |
Why?
|
| Binding Sites | 52 | 2020 | 6023 | 1.830 |
Why?
|
| Propofol | 9 | 2020 | 608 | 1.660 |
Why?
|
| Protein Subunits | 20 | 2020 | 943 | 1.490 |
Why?
|
| Tritium | 16 | 2014 | 707 | 1.360 |
Why?
|
| Diazomethane | 7 | 2018 | 37 | 1.220 |
Why?
|
| Anesthetics, General | 11 | 2020 | 152 | 1.140 |
Why?
|
| Ion Channels | 11 | 2013 | 1044 | 1.080 |
Why?
|
| Azirines | 11 | 2012 | 30 | 1.010 |
Why?
|
| Receptors, GABA | 4 | 2020 | 313 | 0.990 |
Why?
|
| Steroids | 3 | 2020 | 938 | 0.980 |
Why?
|
| Models, Molecular | 23 | 2020 | 5404 | 0.870 |
Why?
|
| Pregnanolone | 2 | 2020 | 67 | 0.790 |
Why?
|
| Electric Organ | 12 | 2000 | 55 | 0.750 |
Why?
|
| Muscle Proteins | 7 | 2016 | 1165 | 0.740 |
Why?
|
| Affinity Labels | 10 | 2013 | 107 | 0.720 |
Why?
|
| Receptors, Cholinergic | 5 | 2005 | 244 | 0.710 |
Why?
|
| Tetracaine | 4 | 2019 | 34 | 0.680 |
Why?
|
| Benzoylcholine | 3 | 2005 | 3 | 0.660 |
Why?
|
| Allosteric Regulation | 12 | 2020 | 424 | 0.660 |
Why?
|
| Anesthetics, Intravenous | 4 | 2018 | 397 | 0.610 |
Why?
|
| Protein Structure, Secondary | 10 | 2013 | 1216 | 0.610 |
Why?
|
| Cell Membrane | 21 | 2012 | 3659 | 0.590 |
Why?
|
| Protein Structure, Tertiary | 13 | 2015 | 3775 | 0.570 |
Why?
|
| Mephobarbital | 2 | 2014 | 7 | 0.570 |
Why?
|
| Anesthetics | 4 | 2020 | 525 | 0.540 |
Why?
|
| Amino Acid Sequence | 30 | 2014 | 13427 | 0.530 |
Why?
|
| Indole Alkaloids | 1 | 2015 | 23 | 0.500 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2015 | 29 | 0.500 |
Why?
|
| Binding, Competitive | 9 | 2020 | 1142 | 0.490 |
Why?
|
| Xenopus laevis | 10 | 2020 | 966 | 0.470 |
Why?
|
| Amino Acids | 8 | 2009 | 1716 | 0.460 |
Why?
|
| gamma-Aminobutyric Acid | 7 | 2020 | 1143 | 0.440 |
Why?
|
| Molecular Sequence Data | 28 | 2014 | 17629 | 0.440 |
Why?
|
| Radioligand Assay | 7 | 2016 | 367 | 0.430 |
Why?
|
| Physostigmine | 1 | 2013 | 50 | 0.420 |
Why?
|
| Cholinergic Agonists | 1 | 2013 | 75 | 0.420 |
Why?
|
| Galantamine | 1 | 2013 | 33 | 0.420 |
Why?
|
| HEK293 Cells | 7 | 2020 | 4291 | 0.410 |
Why?
|
| Kinetics | 14 | 2016 | 6334 | 0.410 |
Why?
|
| Embolism | 1 | 2016 | 401 | 0.410 |
Why?
|
| Chromatography, High Pressure Liquid | 14 | 2013 | 1539 | 0.400 |
Why?
|
| Animals | 84 | 2020 | 169408 | 0.400 |
Why?
|
| Tubocurarine | 6 | 2006 | 62 | 0.400 |
Why?
|
| Peptide Mapping | 8 | 2012 | 260 | 0.380 |
Why?
|
| Craniotomy | 1 | 2016 | 747 | 0.370 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2013 | 241 | 0.370 |
Why?
|
| Xenopus | 10 | 2020 | 711 | 0.360 |
Why?
|
| Hypnotics and Sedatives | 3 | 2020 | 1190 | 0.360 |
Why?
|
| Bone Cements | 1 | 2012 | 327 | 0.350 |
Why?
|
| Benzophenones | 2 | 2007 | 57 | 0.350 |
Why?
|
| Chlorpromazine | 1 | 2009 | 111 | 0.340 |
Why?
|
| Acetylcholine | 7 | 2009 | 629 | 0.330 |
Why?
|
| Diazepam | 2 | 2020 | 214 | 0.330 |
Why?
|
| Tryptophan | 3 | 2003 | 482 | 0.330 |
Why?
|
| Azides | 4 | 2012 | 120 | 0.330 |
Why?
|
| Protein Conformation | 12 | 2016 | 3956 | 0.330 |
Why?
|
| Choice Behavior | 2 | 2006 | 848 | 0.320 |
Why?
|
| Phencyclidine | 4 | 2008 | 59 | 0.310 |
Why?
|
| Photochemistry | 6 | 2013 | 238 | 0.300 |
Why?
|
| Oocytes | 11 | 2018 | 1172 | 0.300 |
Why?
|
| Amphibian Venoms | 3 | 2003 | 5 | 0.270 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2020 | 10778 | 0.270 |
Why?
|
| Ion Channel Gating | 7 | 2011 | 429 | 0.260 |
Why?
|
| Ligands | 10 | 2017 | 3283 | 0.260 |
Why?
|
| Neuromuscular Junction | 3 | 2004 | 407 | 0.260 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2005 | 1629 | 0.260 |
Why?
|
| Tyrosine | 5 | 2009 | 1427 | 0.250 |
Why?
|
| Anesthesiology | 1 | 2016 | 1137 | 0.250 |
Why?
|
| Conotoxins | 3 | 2006 | 20 | 0.250 |
Why?
|
| Octanols | 3 | 2010 | 25 | 0.250 |
Why?
|
| Ethyl Methanesulfonate | 2 | 2002 | 29 | 0.250 |
Why?
|
| Protein Binding | 11 | 2013 | 9344 | 0.240 |
Why?
|
| Lipid Metabolism | 3 | 2008 | 1904 | 0.240 |
Why?
|
| Protein Sorting Signals | 1 | 2005 | 274 | 0.240 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 10 | 2007 | 1731 | 0.240 |
Why?
|
| Agrin | 2 | 2004 | 75 | 0.240 |
Why?
|
| Iodine Radioisotopes | 9 | 2008 | 1034 | 0.230 |
Why?
|
| Protein Structure, Quaternary | 3 | 2016 | 426 | 0.220 |
Why?
|
| Peptide Fragments | 16 | 2007 | 5150 | 0.220 |
Why?
|
| Halothane | 1 | 2003 | 200 | 0.220 |
Why?
|
| Neuregulin-1 | 1 | 2004 | 136 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 4415 | 0.210 |
Why?
|
| Sequence Analysis, Protein | 3 | 2013 | 265 | 0.210 |
Why?
|
| Carbachol | 5 | 2003 | 223 | 0.210 |
Why?
|
| Synaptic Membranes | 4 | 1996 | 89 | 0.210 |
Why?
|
| Allosteric Site | 3 | 2013 | 105 | 0.200 |
Why?
|
| Diazonium Compounds | 2 | 2001 | 17 | 0.200 |
Why?
|
| Models, Chemical | 4 | 2006 | 611 | 0.190 |
Why?
|
| Neuregulins | 1 | 2000 | 36 | 0.180 |
Why?
|
| Ethidium | 1 | 2000 | 27 | 0.180 |
Why?
|
| Choline | 1 | 2003 | 522 | 0.180 |
Why?
|
| Light | 5 | 2012 | 1356 | 0.180 |
Why?
|
| Fluorenes | 2 | 2001 | 160 | 0.180 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2004 | 553 | 0.180 |
Why?
|
| Patch-Clamp Techniques | 5 | 2016 | 927 | 0.180 |
Why?
|
| Models, Neurological | 2 | 2006 | 1783 | 0.180 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 3839 | 0.180 |
Why?
|
| Cattle | 8 | 2010 | 3820 | 0.170 |
Why?
|
| Nicotine | 2 | 1998 | 681 | 0.170 |
Why?
|
| Ceramides | 1 | 2001 | 203 | 0.170 |
Why?
|
| Cysteine | 2 | 2002 | 897 | 0.170 |
Why?
|
| Recombinant Proteins | 4 | 2016 | 6512 | 0.170 |
Why?
|
| Promegestone | 1 | 1999 | 9 | 0.160 |
Why?
|
| Phenylalanine | 2 | 2006 | 368 | 0.160 |
Why?
|
| Bicuculline | 1 | 2019 | 96 | 0.160 |
Why?
|
| Progesterone Congeners | 1 | 1999 | 43 | 0.160 |
Why?
|
| Muscles | 3 | 2015 | 1582 | 0.160 |
Why?
|
| Hydrolysis | 4 | 2013 | 646 | 0.160 |
Why?
|
| Structure-Activity Relationship | 6 | 2020 | 3056 | 0.160 |
Why?
|
| Pulmonary Embolism | 1 | 2012 | 2598 | 0.160 |
Why?
|
| Anesthetics, Inhalation | 1 | 2003 | 573 | 0.150 |
Why?
|
| Receptor Aggregation | 1 | 1998 | 72 | 0.150 |
Why?
|
| Membrane Lipids | 1 | 1999 | 252 | 0.150 |
Why?
|
| Trypsin | 6 | 1998 | 491 | 0.140 |
Why?
|
| GABA Antagonists | 1 | 2017 | 119 | 0.140 |
Why?
|
| Pregnanediones | 1 | 2017 | 11 | 0.140 |
Why?
|
| Dopamine | 1 | 2004 | 1617 | 0.140 |
Why?
|
| Methionine | 2 | 2012 | 573 | 0.140 |
Why?
|
| Serine Endopeptidases | 6 | 2000 | 1027 | 0.130 |
Why?
|
| Solubility | 4 | 2012 | 1087 | 0.130 |
Why?
|
| Photolysis | 1 | 2016 | 94 | 0.130 |
Why?
|
| Membrane Proteins | 5 | 2001 | 7885 | 0.130 |
Why?
|
| GABA Agents | 1 | 2016 | 41 | 0.130 |
Why?
|
| Protein Isoforms | 2 | 2016 | 1714 | 0.130 |
Why?
|
| Molecular Weight | 7 | 2001 | 2173 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 1 | 2001 | 1328 | 0.120 |
Why?
|
| Arginine | 1 | 1999 | 932 | 0.120 |
Why?
|
| Peptides | 3 | 2004 | 4353 | 0.120 |
Why?
|
| Protein Multimerization | 1 | 2020 | 968 | 0.120 |
Why?
|
| Proadifen | 2 | 2006 | 11 | 0.120 |
Why?
|
| Bungarotoxins | 3 | 2009 | 47 | 0.120 |
Why?
|
| Neurotransmitter Agents | 1 | 2018 | 665 | 0.120 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2006 | 466 | 0.120 |
Why?
|
| Isoxazoles | 1 | 2016 | 233 | 0.120 |
Why?
|
| Ligand-Gated Ion Channels | 1 | 2013 | 8 | 0.110 |
Why?
|
| Amino Acid Substitution | 3 | 2006 | 1741 | 0.110 |
Why?
|
| Substance P | 1 | 1994 | 332 | 0.110 |
Why?
|
| Triazoles | 1 | 2019 | 904 | 0.110 |
Why?
|
| Humans | 39 | 2020 | 768887 | 0.110 |
Why?
|
| Sequence Alignment | 3 | 2005 | 2179 | 0.110 |
Why?
|
| Cell Line | 7 | 2009 | 15603 | 0.110 |
Why?
|
| Cholinergic Agents | 1 | 2013 | 97 | 0.110 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 2 | 2010 | 45 | 0.110 |
Why?
|
| Methylmethacrylate | 1 | 2012 | 39 | 0.100 |
Why?
|
| Myristic Acids | 2 | 1989 | 49 | 0.100 |
Why?
|
| Hodgkin Disease | 1 | 2020 | 1384 | 0.100 |
Why?
|
| Macromolecular Substances | 5 | 1998 | 1435 | 0.100 |
Why?
|
| Mutagenesis | 3 | 2002 | 1229 | 0.100 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 3538 | 0.100 |
Why?
|
| Cognition | 3 | 2008 | 7080 | 0.090 |
Why?
|
| Substrate Specificity | 3 | 2012 | 1751 | 0.090 |
Why?
|
| Alkylation | 3 | 2000 | 84 | 0.090 |
Why?
|
| Mesylates | 2 | 2002 | 37 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1836 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2007 | 2749 | 0.090 |
Why?
|
| Brain Mapping | 1 | 2006 | 6740 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 3714 | 0.090 |
Why?
|
| Bupropion | 1 | 2012 | 304 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 610 | 0.080 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2003 | 480 | 0.080 |
Why?
|
| Electrophysiology | 2 | 2005 | 1266 | 0.080 |
Why?
|
| Databases, Protein | 1 | 2012 | 390 | 0.080 |
Why?
|
| Ultraviolet Rays | 3 | 2004 | 1104 | 0.080 |
Why?
|
| DNA Mutational Analysis | 3 | 2005 | 4123 | 0.080 |
Why?
|
| Fluorescent Dyes | 6 | 2006 | 1933 | 0.080 |
Why?
|
| Cholates | 1 | 2008 | 4 | 0.080 |
Why?
|
| Glutamine | 1 | 1992 | 578 | 0.080 |
Why?
|
| GABA Agonists | 2 | 2006 | 106 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 427 | 0.080 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2008 | 162 | 0.080 |
Why?
|
| Sequence Analysis | 2 | 1999 | 240 | 0.080 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2020 | 452 | 0.080 |
Why?
|
| Larva | 5 | 2011 | 514 | 0.080 |
Why?
|
| Rats | 5 | 2005 | 23847 | 0.070 |
Why?
|
| Foreign Bodies | 1 | 2012 | 403 | 0.070 |
Why?
|
| Cytoplasm | 2 | 1990 | 1505 | 0.070 |
Why?
|
| Immunoblotting | 3 | 2002 | 1647 | 0.070 |
Why?
|
| Cyanogen Bromide | 3 | 1992 | 75 | 0.070 |
Why?
|
| Thoracic Vertebrae | 1 | 2012 | 614 | 0.070 |
Why?
|
| Pyrenes | 2 | 2001 | 51 | 0.070 |
Why?
|
| Molecular Structure | 3 | 2020 | 1885 | 0.070 |
Why?
|
| Muscimol | 1 | 2006 | 70 | 0.070 |
Why?
|
| Brain | 5 | 2006 | 27476 | 0.070 |
Why?
|
| Myristic Acid | 2 | 2000 | 49 | 0.070 |
Why?
|
| Hypotension | 1 | 2012 | 888 | 0.070 |
Why?
|
| Syndrome | 1 | 2012 | 3274 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2006 | 527 | 0.060 |
Why?
|
| Lidocaine | 1 | 2009 | 546 | 0.060 |
Why?
|
| Learning | 2 | 2006 | 1761 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2016 | 2029 | 0.060 |
Why?
|
| Isoflurane | 2 | 2010 | 384 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 3744 | 0.060 |
Why?
|
| Caveolin 3 | 1 | 2004 | 24 | 0.060 |
Why?
|
| Oncogene Proteins v-erbB | 1 | 2004 | 17 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2009 | 880 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2008 | 1081 | 0.060 |
Why?
|
| Transcription Factor AP-2 | 1 | 2004 | 79 | 0.060 |
Why?
|
| Stereoisomerism | 3 | 2012 | 612 | 0.060 |
Why?
|
| Caveolins | 1 | 2004 | 102 | 0.060 |
Why?
|
| Quaternary Ammonium Compounds | 2 | 2006 | 204 | 0.060 |
Why?
|
| Cross-Linking Reagents | 3 | 2006 | 692 | 0.060 |
Why?
|
| Tachycardia, Ventricular | 1 | 2012 | 1309 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6085 | 0.050 |
Why?
|
| Epitopes | 1 | 1990 | 2529 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2010 | 1683 | 0.050 |
Why?
|
| Ions | 1 | 2004 | 256 | 0.050 |
Why?
|
| Mollusca | 1 | 2002 | 41 | 0.050 |
Why?
|
| Microscopy, Electron | 2 | 2000 | 2560 | 0.050 |
Why?
|
| Carbon Radioisotopes | 1 | 2003 | 567 | 0.050 |
Why?
|
| Proton-Translocating ATPases | 1 | 2002 | 112 | 0.050 |
Why?
|
| Detergents | 1 | 2002 | 235 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2000 | 2475 | 0.050 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2001 | 15 | 0.050 |
Why?
|
| Utrophin | 1 | 2001 | 15 | 0.050 |
Why?
|
| Annexins | 1 | 2001 | 40 | 0.050 |
Why?
|
| Dystroglycans | 1 | 2001 | 62 | 0.050 |
Why?
|
| Radiography | 1 | 2012 | 6991 | 0.050 |
Why?
|
| Porins | 1 | 2001 | 78 | 0.050 |
Why?
|
| Models, Structural | 2 | 1992 | 340 | 0.050 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 2000 | 16 | 0.050 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2000 | 25 | 0.050 |
Why?
|
| Drug Antagonism | 1 | 2020 | 50 | 0.050 |
Why?
|
| Flumazenil | 1 | 2020 | 84 | 0.040 |
Why?
|
| Databases as Topic | 1 | 2002 | 475 | 0.040 |
Why?
|
| GABA Modulators | 1 | 2020 | 109 | 0.040 |
Why?
|
| Receptors, Muscarinic | 1 | 2000 | 157 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2012 | 3840 | 0.040 |
Why?
|
| Photochemical Processes | 1 | 2020 | 85 | 0.040 |
Why?
|
| Schwann Cells | 1 | 2000 | 196 | 0.040 |
Why?
|
| Computers | 1 | 2002 | 592 | 0.040 |
Why?
|
| Receptor, erbB-3 | 1 | 2000 | 143 | 0.040 |
Why?
|
| Mollusk Venoms | 1 | 1999 | 19 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 2000 | 1990 | 0.040 |
Why?
|
| Affect | 1 | 2007 | 1500 | 0.040 |
Why?
|
| Freeze Etching | 2 | 1990 | 9 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 2000 | 455 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2006 | 5035 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2012 | 6001 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2000 | 329 | 0.040 |
Why?
|
| Membranes | 1 | 1999 | 164 | 0.040 |
Why?
|
| Zebrafish | 2 | 2020 | 3037 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 930 | 0.040 |
Why?
|
| Presynaptic Terminals | 1 | 2000 | 302 | 0.040 |
Why?
|
| Hexosaminidases | 1 | 1997 | 45 | 0.040 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1997 | 26 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 839 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2001 | 1162 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2008 | 7148 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2000 | 921 | 0.040 |
Why?
|
| GABA-A Receptor Agonists | 2 | 2009 | 86 | 0.040 |
Why?
|
| Schizophrenia | 2 | 2008 | 6987 | 0.040 |
Why?
|
| Pyridines | 1 | 2009 | 2896 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 13020 | 0.030 |
Why?
|
| Peptides, Cyclic | 1 | 1999 | 391 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 1997 | 160 | 0.030 |
Why?
|
| Imidazoles | 1 | 2003 | 1169 | 0.030 |
Why?
|
| Cognition Disorders | 2 | 2008 | 3985 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2017 | 198 | 0.030 |
Why?
|
| Cholesterol | 1 | 2006 | 2913 | 0.030 |
Why?
|
| Female | 11 | 2020 | 397464 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2001 | 1421 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2002 | 1139 | 0.030 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 1996 | 60 | 0.030 |
Why?
|
| Plasmids | 1 | 2000 | 2269 | 0.030 |
Why?
|
| Mice | 7 | 2009 | 82074 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2005 | 4178 | 0.030 |
Why?
|
| Nerve Net | 1 | 2007 | 2361 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 2067 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2002 | 1438 | 0.030 |
Why?
|
| Dystrophin | 1 | 1996 | 284 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2000 | 1973 | 0.030 |
Why?
|
| Progesterone | 1 | 1999 | 752 | 0.030 |
Why?
|
| Ketamine | 1 | 2020 | 527 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2001 | 1004 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2000 | 2003 | 0.030 |
Why?
|
| Models, Animal | 1 | 2020 | 2123 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2020 | 65485 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2000 | 2635 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2000 | 2674 | 0.030 |
Why?
|
| Reflex | 2 | 2006 | 375 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 1209 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 1999 | 1058 | 0.030 |
Why?
|
| Transfection | 1 | 2000 | 5763 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2000 | 1430 | 0.030 |
Why?
|
| Algorithms | 1 | 2013 | 14199 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2885 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1992 | 637 | 0.020 |
Why?
|
| Chymotrypsin | 1 | 1991 | 137 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2006 | 694 | 0.020 |
Why?
|
| Cations | 1 | 1991 | 240 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1667 | 0.020 |
Why?
|
| Serotonin 5-HT3 Receptor Antagonists | 1 | 2010 | 23 | 0.020 |
Why?
|
| Glutathione Disulfide | 1 | 1990 | 32 | 0.020 |
Why?
|
| Mutation | 3 | 2016 | 30266 | 0.020 |
Why?
|
| Neuropeptides | 1 | 1996 | 951 | 0.020 |
Why?
|
| Internet | 1 | 2002 | 3112 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2000 | 2606 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2006 | 508 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2007 | 4819 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 8200 | 0.020 |
Why?
|
| Synapses | 2 | 1990 | 1766 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2009 | 86 | 0.020 |
Why?
|
| Myristates | 1 | 1988 | 12 | 0.020 |
Why?
|
| Neurons | 1 | 2007 | 9524 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2009 | 395 | 0.020 |
Why?
|
| Software | 1 | 2002 | 4480 | 0.020 |
Why?
|
| Iodoacetamide | 1 | 1987 | 33 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2004 | 4429 | 0.020 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2008 | 108 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 3 | 1990 | 9264 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1987 | 174 | 0.020 |
Why?
|
| Glutathione | 1 | 1990 | 589 | 0.020 |
Why?
|
| Chickens | 1 | 1989 | 845 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 1987 | 247 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1996 | 2452 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1991 | 2488 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 9618 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2007 | 525 | 0.020 |
Why?
|
| Dansyl Compounds | 1 | 2006 | 19 | 0.020 |
Why?
|
| Sodium | 1 | 1991 | 1597 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2000 | 7609 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2009 | 371 | 0.020 |
Why?
|
| Molecular Probes | 1 | 2007 | 309 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 5803 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 4980 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 1629 | 0.020 |
Why?
|
| Aziridines | 1 | 2005 | 23 | 0.020 |
Why?
|
| Time Factors | 3 | 2005 | 40266 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 1002 | 0.020 |
Why?
|
| Temperature | 1 | 1991 | 2235 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 1952 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 12174 | 0.010 |
Why?
|
| Ethanol | 1 | 2010 | 1332 | 0.010 |
Why?
|
| Advisory Committees | 1 | 2008 | 797 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1989 | 1194 | 0.010 |
Why?
|
| Drug Design | 1 | 2008 | 1046 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1990 | 3814 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 691 | 0.010 |
Why?
|
| Psychotropic Drugs | 1 | 2008 | 883 | 0.010 |
Why?
|
| Play and Playthings | 1 | 2002 | 85 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 1989 | 2204 | 0.010 |
Why?
|
| Diphenylhexatriene | 1 | 2001 | 12 | 0.010 |
Why?
|
| Face | 1 | 2007 | 1031 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1989 | 2202 | 0.010 |
Why?
|
| Gyrus Cinguli | 1 | 2007 | 1136 | 0.010 |
Why?
|
| Schizophrenic Psychology | 1 | 2008 | 1651 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1989 | 6232 | 0.010 |
Why?
|
| Rana pipiens | 1 | 1999 | 64 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2012 | 2914 | 0.010 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 5834 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 171790 | 0.010 |
Why?
|
| Amygdala | 1 | 2007 | 1382 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2007 | 36861 | 0.010 |
Why?
|
| Visual Perception | 1 | 2007 | 1407 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 2001 | 379 | 0.010 |
Why?
|
| Fear | 1 | 2007 | 1494 | 0.010 |
Why?
|
| Psychometrics | 1 | 2008 | 3066 | 0.010 |
Why?
|
| Consensus | 1 | 2008 | 3214 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2000 | 23652 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1990 | 19023 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41800 | 0.010 |
Why?
|
| Phospholipids | 1 | 2001 | 787 | 0.010 |
Why?
|
| Attention | 1 | 2007 | 2425 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 3724 | 0.010 |
Why?
|
| Equipment Design | 1 | 2002 | 3529 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1987 | 11119 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9499 | 0.010 |
Why?
|
| Psychotic Disorders | 1 | 2008 | 3279 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 8055 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 81892 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1996 | 1105 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4168 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 20244 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1990 | 975 | 0.000 |
Why?
|
| Precipitin Tests | 1 | 1988 | 816 | 0.000 |
Why?
|
| RNA | 1 | 1996 | 2727 | 0.000 |
Why?
|
| Base Sequence | 1 | 1996 | 12430 | 0.000 |
Why?
|
| Adult | 2 | 2008 | 223818 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1990 | 6346 | 0.000 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1988 | 1966 | 0.000 |
Why?
|
| United States | 1 | 2008 | 73180 | 0.000 |
Why?
|
| Male | 2 | 2008 | 365249 | 0.000 |
Why?
|